|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-2-18
|
|
pubmed:abstractText |
An unbiased genetic approach was used to identify a specific amino acid residue in the alphaIIb subunit important for the ligand binding function of the integrin alphaIIbbeta. Chemically mutagenized cells were selected by flow cytometry based on their inability to bind the ligand mimetic antibody PAC1 and a cell line containing a single amino acid substitution in alphaIIb at position 224 (D-->V) was identified. Although well expressed on the surface of transfected cells, alphaIIbD224Vbeta3 as well as alphaIIbD224Abeta3 did not bind alphaIIbbeta3-specific ligands or a RGD peptide, a ligand shared in common with alphavbeta3. Insertion of exon 5 of alphaIIb, residues G193-W235, into the backbone of the alphav subunit did not enable the chimeric receptor to bind alphaIIbbeta3-specific ligands. However, the chimeric receptor was still capable of binding to a RGD affinity matrix. alphaIIbD224 is not well conserved among other integrin alpha subunits and is located in a region of significant variability. In addition, amino acid D224 lies within a predicted loop of the recently proposed beta-propeller model for integrin alpha subunits and is adjacent to a loop containing amino acid residues previously implicated in receptor function. These data support a role for this region in ligand binding function of the alphaIIbbeta3 receptor.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0006-4971
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
918-24
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9920841-Amino Acid Sequence,
pubmed-meshheading:9920841-Amino Acid Substitution,
pubmed-meshheading:9920841-Animals,
pubmed-meshheading:9920841-Antibodies, Monoclonal,
pubmed-meshheading:9920841-Binding Sites,
pubmed-meshheading:9920841-CHO Cells,
pubmed-meshheading:9920841-Cricetinae,
pubmed-meshheading:9920841-Cricetulus,
pubmed-meshheading:9920841-Exons,
pubmed-meshheading:9920841-Fibrinogen,
pubmed-meshheading:9920841-Humans,
pubmed-meshheading:9920841-Ligands,
pubmed-meshheading:9920841-Molecular Sequence Data,
pubmed-meshheading:9920841-Mutagenesis, Site-Directed,
pubmed-meshheading:9920841-Oligopeptides,
pubmed-meshheading:9920841-Platelet Adhesiveness,
pubmed-meshheading:9920841-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:9920841-Point Mutation,
pubmed-meshheading:9920841-Protein Binding,
pubmed-meshheading:9920841-Protein Conformation,
pubmed-meshheading:9920841-Recombinant Fusion Proteins,
pubmed-meshheading:9920841-Sequence Alignment,
pubmed-meshheading:9920841-Sequence Homology, Amino Acid,
pubmed-meshheading:9920841-Structure-Activity Relationship,
pubmed-meshheading:9920841-Transfection
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
A mutation in the alpha subunit of the platelet integrin alphaIIbbeta3 identifies a novel region important for ligand binding.
|
|
pubmed:affiliation |
Department of Vascular Biology, The Scripps Research Institute, La Jolla, CA, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
